Bear, DE, United States of America

Goss S Kauffman


Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Goss S. Kauffman: A Journey Through Patents in Pharmaceutical Advancements

Introduction: Goss S. Kauffman, based in Bear, Delaware, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With two patents to his name, his work focuses on developing innovative compounds that have significant implications in the treatment of various medical conditions, particularly in the realm of HIV and platelet aggregation.

Latest Patents: Kauffman's latest patents showcase his ingenuity. The first patent, titled "Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors," describes a method for synthesizing quinazolin-2-ones, which play a crucial role as inhibitors for HIV reverse transcriptase. This synthesis utilizes chiral ligand-mediated addition of cyclopropylacetylide, highlighting Kauffman’s innovative approach to combating HIV.

The second patent, "Crystalline roxifiban," relates to the development of roxifiban in a crystalline form. This potent platelet glycoprotein IIb/IIIa antagonist exists in two polymorphic forms, which are meticulously characterized by x-ray powder diffraction and solid-state carbon NMR. The patent also describes various pharmaceutical compositions and methods aimed at treating or preventing diseases that are mediated by platelet aggregation.

Career Highlights: Throughout his career, Goss S. Kauffman has made significant strides in pharmaceutical research, working for esteemed organizations such as DuPont Pharmaceuticals Company and Bristol-Myers Squibb Pharma Corporation. His tenure at these companies allowed him to develop various groundbreaking therapies that enhance medical treatments available today.

Collaborations: In his innovative journey, Kauffman has collaborated with notable colleagues, including Michael B. Maurin and Philip Ma, who have contributed to the success of his research and development efforts. These collaborations underscore the importance of teamwork in advancing scientific innovation in the pharmaceutical sector.

Conclusion: Goss S. Kauffman exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to developing effective medications, as reflected in his patents, continues to have a substantial impact on medical science and patient care. As he furthers his research, the potential for new discoveries and therapies remains vast, marking Kauffman as a pivotal figure in the field of pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…